Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

FDA approves ANDA for Oruvail

April 7, 1999

Prosorba Column now available in U.S. for treatment of rheumatoid arthritis

April 6, 1999

Bioniche enters supply agreement with Sanova for Suplasyn

April 6, 1999

Anika to initiate Orthovisc phase III clinical study in U.S. and Canada

April 5, 1999

New oral SLE therapy GL-701 awarded fast track designation

April 5, 1999

Cypress Bioscience closes partnership agreement with Fresenius

April 5, 1999

Celecoxib is an effective antipyretic agent in man

March 26, 1999

Celgene synthesizes potent TNF-alpha and PDE4 inhibitors

March 26, 1999

FDA grants orphan drug status to recombinant Pharming product

March 26, 1999

Inhibitors of MCP-1 disclosed by Zeneca for inflammation

March 25, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...